Episomal vectors to monitor and induce somatic hypermutation in human Burkitt-Lymphoma cell lines

Molecular Immunology

Volumn 43, Issue 10, 2006, Pages 1645-1652

  Rückerl, Florian ^a   Busse, Birgit ^a   Bachl, Jurgen ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Activation induced cytidine deaminase; Burkitt's Lymphoma; Episomal vectors; GFP reversion assay; Somatic hypermutation

Indexed keywords

CYTIDINE DEAMINASE; GREEN FLUORESCENT PROTEIN; IMMUNOGLOBULIN G;

AMINO ACID SEQUENCE; ARTICLE; BURKITT LYMPHOMA; EPISOME; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RAJI CELL; SOMATIC HYPERMUTATION; TUMOR CELL LINE;

BURKITT LYMPHOMA; CELL LINE, TUMOR; CYTIDINE DEAMINASE; CYTOSINE DEAMINASE; ENHANCER ELEMENTS (GENETICS); GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOGLOBULINS; MUTAGENESIS; PLASMIDS; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN;

EID: 33644543350     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2005.09.011     Document Type: Article

References (35)

1. A. Aiello, D. Delia, E. Fontanella, R. Giardini, F. Rilke, and G. Della Porta Expression of differentiation and adhesion molecules in sporadic Burkitt's lymphoma Hematol. Oncol. 8 1990 229 238
2. T. Albert, B. Urlbauer, F. Kohlhuber, B. Hammersen, and D. Eick Ongoing mutations in the N-terminal domain of c-Myc affect transactivation in Burkitt's lymphoma cell lines Oncogene 9 1994 759 763
3. H. Arakawa, J. Hauschild, and J.M. Buerstedde Requirement of the activation-induced deaminase (AID) gene for immunoglobulin gene conversion Science 295 2002 1301 1306
4. J. Bachl, C. Carlson, V. Gray-Schopfer, M. Dessing, and C. Olsson Increased transcription levels induce higher mutation rates in a hypermutating cell line J. Immunol. 166 2001 5051 5057
5. J. Bachl, and C. Olsson Hypermutation targets a green fluorescent protein-encoding transgene in the presence of immunoglobulin enhancers Eur. J. Immunol. 29 1999 1383 1389
6. J. Bachl, C. Olsson, N. Chitkara, and M. Wabl The Ig mutator is dependent on the presence, position, and orientation of the large intron enhancer Proc. Natl. Acad. Sci. U.S.A. 95 1998 2396 2399
7. M. Bemark, and M.S. Neuberger By-products of immunoglobulin somatic hypermutation Genes Chromosomes Cancer 38 2003 32 39
8. G.W. Bornkamm, C. Berens, C. Kuklik-Roos, J.M. Bechet, G. Laux, J. Bachl, M. Korndoerfer, M. Schlee, M. Holzel, A. Malamoussi, R.D. Chapman, F. Nimmerjahn, J. Mautner, W. Hillen, H. Bujard, and J. Feuillard Stringent doxycycline-dependent control of gene activities using an episomal one-vector system Nucleic Acids Res 33 2005 e137
9. C.J. Chapman, D. Wright, and F.K. Stevenson Insight into Burkitt's lymphoma from immunoglobulin variable region gene analysis Leuk. Lymphoma 30 1998 257 267
10. R. Dalla-Favera, M. Bregni, J. Erikson, D. Patterson, R.C. Gallo, and C.M. Croce Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells Proc. Natl. Acad. Sci. U.S.A. 79 1982 7824 7827
11. S. Denepoux, D. Razanajaona, D. Blanchard, G. Meffre, J.D. Capra, J. Banchereau, and S. Lebecque Induction of somatic mutation in a human B cell line in vitro Immunity 6 1997 35 46
12. A. Faili, S. Aoufouchi, Q. Gueranger, C. Zober, A. Leon, B. Bertocci, J.C. Weill, and C.A. Reynaud AID-dependent somatic hypermutation occurs as a DNA single-strand event in the BL2 cell line Nat. Immunol. 3 2002 815 821
13. M.C. Favrot, O. Maritaz, T. Suzuki, M. Cooper, I. Philip, T. Philip, and G. Lenoir EBV-negative and -positive Burkitt cell lines variably express receptors for B-cell activation and differentiation Int. J. Cancer 38 1986 901 906
14. Y. Fukita, H. Jacobs, and K. Rajewsky Somatic hypermutation in the heavy chain locus correlates with transcription Immunity 9 1998 105 114
15. T. Goossens, U. Klein, and R. Kuppers Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease Proc. Natl. Acad. Sci. U.S.A. 95 1998 2463 2468
16. J. Greeve, A. Philipsen, K. Krause, W. Klapper, K. Heidorn, B.E. Castle, J. Janda, K.B. Marcu, and R. Parwaresch Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas Blood 101 2003 3574 3580
17. M.S. Hardianti, E. Tatsumi, M. Syampurnawati, K. Furuta, K. Saigo, S. Kawano, S. Kumagai, F. Nakamura, and Y. Matsuo Expression of activation-induced cytidine deaminase (AID) in Burkitt lymphoma cells: rare AID-negative cell lines with the unmutated rearranged VH gene Leuk. Lymphoma 45 2004 155 160
18. E. Hsu Mutation, selection, and memory in B lymphocytes of exothermic vertebrates Immunol. Rev. 162 1998 25 36
19. U. Klein, T. Goossens, M. Fischer, H. Kanzler, A. Braeuninger, K. Rajewsky, and R. Kuppers Somatic hypermutation in normal and transformed human B cells Immunol. Rev. 162 1998 261 280
20. R. Kuppers, and R. Dalla-Favera Mechanisms of chromosomal translocations in B cell lymphomas Oncogene 20 2001 5580 5594
21. K. Machida, K.T. Cheng, V.M. Sung, S. Shimodaira, K.L. Lindsay, A.M. Levine, M.Y. Lai, and M.M. Lai Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes Proc. Natl. Acad. Sci. U.S.A. 101 2004 4262 4267
22. A. Martin, and M.D. Scharff Somatic hypermutation of the AID transgene in B and non-B cells Proc. Natl. Acad. Sci. U.S.A. 99 2002 12304 12308
23. K.M. McBride, V. Barreto, A.R. Ramiro, P. Stavropoulos, and M.C. Nussenzweig Somatic hypermutation is limited by CRM1-dependent nuclear export of activation-induced deaminase J. Exp. Med. 199 2004 1235 1244
24. A. Migliazza, S. Martinotti, W. Chen, C. Fusco, B.H. Ye, D.M. Knowles, K. Offit, R.S. Chaganti, and R. Dalla-Favera Frequent somatic hypermutation of the 5′ noncoding region of the BCL6 gene in B-cell lymphoma Proc. Natl. Acad. Sci. U.S.A. 92 1995 12520 12524
25. M. Muschen, D. Re, B. Jungnickel, V. Diehl, K. Rajewsky, and R. Kuppers Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal center reaction J. Exp. Med. 192 2000 1833 1840
26. I.M. Okazaki, H. Hiai, N. Kakazu, S. Yamada, M. Muramatsu, K. Kinoshita, and T. Honjo Constitutive expression of AID leads to tumorigenesis J. Exp. Med. 197 2003 1173 1181
27. L. Pasqualucci, P. Neumeister, T. Goossens, G. Nanjangud, R.S. Chaganti, R. Kuppers, and R. Dalla-Favera Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas Nature 412 2001 341 346
28. A.R. Ramiro, M. Jankovic, T. Eisenreich, S. Difilippantonio, S. Chen-Kiang, M. Muramatsu, T. Honjo, A. Nussenzweig, and M.C. Nussenzweig AID is required for c-myc/IgH chromosome translocations in vivo Cell 118 2004 431 438
29. F. Ruckerl, R. Mailhammer, and J. Bachl Dual reporter system to dissect cis- and trans-effects influencing the mutation rate in a hypermutating cell line Mol. Immunol. 41 2004 1135 1143
30. J.E. Sale, and M.S. Neuberger TdT-accessible breaks are scattered over the immunoglobulin V domain in a constitutively hypermutating B cell line Immunity 9 1998 859 869
31. R. Taub, I. Kirsch, C. Morton, G. Lenoir, D. Swan, S. Tronick, S. Aaronson, and P. Leder Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells Proc. Natl. Acad. Sci. U.S.A. 79 1982 7837 7841
32. C.L. Wang, R.A. Harper, and M. Wabl Genome-wide somatic hypermutation Proc. Natl. Acad. Sci. U.S.A. 101 2004 7352 7356
33. M. Wilson, E. Hsu, A. Marcuz, M. Courtet, L. Du Pasquier, and C. Steinberg What limits affinity maturation of antibodies in Xenopus - the rate of somatic mutation or the ability to select mutants? EMBO J. 11 1992 4337 4347
34. K. Yoshikawa, I.M. Okazaki, T. Eto, K. Kinoshita, M. Muramatsu, H. Nagaoka, and T. Honjo AID enzyme-induced hypermutation in an actively transcribed gene in fibroblasts Science 296 2002 2033 2036
35. W. Zhang, P.D. Bardwell, C.J. Woo, V. Poltoratsky, M.D. Scharff, and A. Martin Clonal instability of V region hypermutation in the Ramos Burkitt's lymphoma cell line Int. Immunol. 13 2001 1175 1184